A Two-part Study of Lembas Edge Evaluating Tolerability and Postprandial Glycemic Control
Starting soon · Not applicable · Has a placebo group
Conditions studied: Postprandial Glycemic Control, Prediabetic Overweight and Obese Adults
In brief
The goal of part 1 of this clinical trial is to investigate the tolerability of Lembas Edge in healthy adults. The objective of Part 2 of this study is to investigate the efficacy of Lembas Edge on postprandial glycemic control in prediabetic overweight and obese adults. The main questions it aims to answer are: * What is the tolerability of Lembas Edge? * What is the efficacy of Lembas Edge on postprandial glycemic control? Researchers will compare Lembas Edge to placebo to see its effects. Participants will be asked to: * Provide blood samples. * Record their food and beverage intake in Part 2. * Complete a satiety questionnaire in Part 2. * Consume Lembas Edge or placebo as instructed.
Key facts
- Study ID
- NCT07711288
- Run by
- Lembas
- People needed
- 35
- Starts
- 2026-09-01
- Expected to finish
- 2027-01-01
- Last updated by the study team
- 2026-07-17
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: accepted.
Where it is running
- KGK Science Inc. — London, Ontario, Canada
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.